Name: JOHNSON PHARMACARE LIMITED Financial Filings and Reports
Creator: FinancialReports
License: https://financialreports.eu/terms/

Filings indexed 300 across all filing types

Latest filing 2026-05-22 Regulatory Filings

Country IN India

Listing BSE.NS 532154

About JOHNSON PHARMACARE LIMITED

Johnson Pharmacare Limited specializes in the wholesale and retail distribution of pharmaceutical products, chemicals, and surgical instruments. Incorporated in 1994, the company manages a diverse portfolio of medical goods, focusing on the procurement and supply of healthcare formulations to various market segments. Its core operations involve the trade of medicinal supplies, ensuring the availability of essential healthcare products through an established distribution network. The company serves as a link between manufacturers and healthcare providers, maintaining a focus on supply chain efficiency and the distribution of a broad range of therapeutic products and medical equipment.

Recent filings

Filing	Released	Lang
Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve To consider and approve .... Regulatory Filings	2026-05-22	English
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars .... Regulatory Filings	2026-05-09	English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... Regulatory Filings	2026-04-30	English
Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015 Regulatory Filings	2026-04-17	English
Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015 Appointment of MR. Nand Kishore Ray as Additional Non -Executive &Non- Independent Director and Appointment of mr. Dheeraj .... Regulatory Filings	2026-04-17	English
1. The Board has appointed Mr. Nand Kishore Ray (DIN: 11626638) as an Additional (Non-Executive & Non-Independent Director) of the Company w.e.f 17th April, 2026 The Board has appointed .... Regulatory Filings	2026-04-17	English

Browse filings by year

8 years

	ID	Filing	Released	Lang
2026 15 filings
	46834128	Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve To consider and approve .... Regulatory Filings	2026-05-22	English
	44723017	Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars .... Regulatory Filings	2026-05-09	English
	46613367	Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details .... Regulatory Filings	2026-04-30	English
	46613369	Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015 Regulatory Filings	2026-04-17	English
	46613376	Disclosure as per Regulation 30 of SEBI (LODR) Regulation 2015 Appointment of MR. Nand Kishore Ray as Additional Non -Executive &Non- Independent Director and Appointment of mr. Dheeraj .... Regulatory Filings	2026-04-17	English
	46613371	1. The Board has appointed Mr. Nand Kishore Ray (DIN: 11626638) as an Additional (Non-Executive & Non-Independent Director) of the Company w.e.f 17th April, 2026 The Board has appointed .... Regulatory Filings	2026-04-17	English
	46613373	Certificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 for the quarter and year ended 31st March, 2026 Regulatory Filings	2026-04-13	English
	46613378	Intimation of Closure of Trading Window as per Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation 2015 for the Quarter and Year Ended on 31st March 2026. Regulatory Filings	2026-03-21	English
	46613387	Disclosure as per Regulation 30 of SEBI LODR Regualtion 2015 for the appointment of Additional Non- Executive & Independent Director. Regulatory Filings	2026-02-17	English
	46613384	Disclosure as per Regulation 30 of SEBI LODR Regulation 2015 for the appointment of Statutory Auditor. Regulatory Filings	2026-02-17	English
	46613394	Revised outcome of Meeting of Board of Directors held on Friday 13th Feburay 2026 at Pursuant to Regulation 30 of SEBI LODR Regulation 2015. Regulatory Filings	2026-02-17	English
	46613381	Submission of Extract of Newspaper Publication of Unaudited (Standalone) Financials Results for the quarter ended on 31st December 2025 Regulatory Filings	2026-02-16	English
	46613397	Undertaking for Non- applicability of reg 32 of sebi (lodr) regualtion 2015 for the quarter ended on 31st December 2025 Regulatory Filings	2026-02-14	English
	46613390	Submission of unaudited (Stanalone) Financials results of (Johnson Pharmacare Limited) for the quarter ended on 31st December 2025 along with limited Review Report Thereon. Regulatory Filings	2026-02-14	English
	46613403	UNAUDITED (STANDALONE) FINANCIAL RESULTS The Board of Director have considered and approved the Unaudited (Standalone) Financial Results along with Limited Review Report thereon for the .... Regulatory Filings	2026-02-14	English

Page 1 of 20

1 2 3 … Next

Market data

Market data not available

Peer group · Wholesale of other household goods

159 peers

Company	Ticker	Country	Sector
111, Inc. A tech-enabled healthcare platform connecting patients with…	YI	KY	Wholesale and retail trade
AAYUSH ART AND BULLION LIMITED Trades and distributes gold and silver bullion, coins, and …	540718	IN	Wholesale and retail trade
Al Hassan Ghazi Ibrahim Shaker Co. Distributes air conditioning, home appliances, and energy m…	1214	SA	Wholesale and retail trade
ALLIANCE ENTERTAINMENT HOLDING CORP Global wholesaler and distributor of home entertainment pro…	AENT	US	Wholesale and retail trade
ALLIANCE PHARMA PLC Specialty pharmaceutical company acquiring and marketing co…	APH	GB	Wholesale and retail trade
ARATA CORPORATION A wholesale trading company distributing daily consumer goo…	2733	JP	Wholesale and retail trade
Asker Healthcare Group AB A partner to caregivers and patients providing medical prod…	ASKER	SE	Wholesale and retail trade
Aspire & Innovative Advertising Limited Distributes consumer durables and electronics via an asset-…	ASPIRE	IN	Wholesale and retail trade
Ausupreme International Holdings Limited Distributor of TGA-certified Australian health foods and We…	2031	HK	Wholesale and retail trade
Avidus Management Group Inc. Marketer and distributor of nutraceutical products, supplem…	ASNHF	CA	Wholesale and retail trade

Page 1 of 16

1 2 3 … Next

JOHNSON PHARMACARE LIMITED via the API

Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.

Get API access Read API reference

Base URLapi.financialreports.eu

Auth headerx-api-key

Company ID63686

Ticker532154

ISININE560F01022

Endpoints

most-used routes for this company

GET	/api/companies/63686/	Company identity, sector, listing, identifiers
GET	/api/filings/?company=63686	Paginated list of all filings (filterable by type, date, language)
GET	/api/filings/{id}/	Single filing — metadata, document URL, processing status
GET	/api/filings/{id}/markdown/	Filing content as Markdown (PDF → text/tables/figures)
GET	/api/isins/?company=63686	All ISINs registered to this company
GET	/api/filing-types/	Reference: every filing-type code + category

Full reference: API reference · OpenAPI schema

cURL

latest filings for JOHNSON PHARMACARE LIMITED

$ curl https://api.financialreports.eu/api/filings/?company=63686 \
    -H "x-api-key: $FR_API_KEY" \
    -H "Accept: application/json"

Python

requests

import requests

r = requests.get(
    "https://api.financialreports.eu/api/filings/",
    params={"company": 63686},
    headers={"x-api-key": API_KEY},
)
filings = r.json()["results"]

MCP server

Claude · Claude Code · ChatGPT

Claude setup ChatGPT setup Claude Code setup

// MCP server URL
https://mcp.financialfilings.com/mcp

// Once connected, the LLM can query this company directly:
"Pull the latest 5 filings for JOHNSON PHARMACARE LIMITED (id: 63686)"

JOHNSON PHARMACARE LIMITED — Investor Relations & Filings